PTHLH and cancer: Nonetheless, furthering our understanding of interactions between pathological mediators such as PTHrP, the signaling mechanisms they employ and their physico-chemical interactions with sensory ion channels will increase the likelihood of developing more efficacious analgesic approaches for debilitating pain states, such as bone-metastasized cancer.